AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,664 | +7.8% | 330,425 | +18.7% | 0.17% | -8.0% |
| Q4 2022 | $3,399 | -99.8% | 278,352 | +28.9% | 0.19% | +38.2% |
| Q3 2022 | $2,254,000 | +306.9% | 215,912 | +318.9% | 0.14% | +223.8% |
| Q2 2022 | $554,000 | -62.2% | 51,548 | -66.7% | 0.04% | -56.2% |
| Q1 2022 | $1,466,000 | +175.0% | 154,799 | +235.6% | 0.10% | +43.3% |
| Q4 2021 | $533,000 | +40.3% | 46,126 | +15.9% | 0.07% | +31.4% |
| Q3 2021 | $380,000 | +104.3% | 39,795 | +106.7% | 0.05% | -19.0% |
| Q2 2021 | $186,000 | -60.1% | 19,254 | -59.1% | 0.06% | -57.7% |
| Q1 2021 | $466,000 | -65.5% | 47,128 | -19.4% | 0.15% | -61.3% |
| Q4 2020 | $1,350,000 | +203.4% | 58,468 | +85.4% | 0.38% | +173.0% |
| Q3 2020 | $445,000 | -61.7% | 31,528 | -59.1% | 0.14% | -64.3% |
| Q2 2020 | $1,162,000 | +27.4% | 77,078 | -21.9% | 0.40% | +2.6% |
| Q1 2020 | $912,000 | – | 98,675 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |